Christine Klemke-Jahn

Title: Christine Klemke-Jahn: Innovator in Macrolactone Derivatives

Introduction

Christine Klemke-Jahn is a notable inventor based in Frankfurt, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolactone derivatives. Her work focuses on compounds that have potential applications in treating fungal disorders.

Latest Patents

Christine holds 1 patent related to macrolactone derivatives. The patent discloses compounds of the formula (I), where R1, R2, R3, and R4 are defined in the disclosure. These compounds, or their pharmaceutically acceptable salts, are formed by the microorganism ST 201196 (DSM 18870). The patent outlines their use for the treatment and/or prophylaxis of fungal disorders, as well as the processes for their production.

Career Highlights

Throughout her career, Christine has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. Her experience in these organizations has allowed her to contribute to significant advancements in drug development.

Collaborations

Christine has collaborated with esteemed colleagues such as Holger Hoffmann and Dietmar Schummer. Their combined expertise has furthered research and innovation in their respective fields.

Conclusion

Christine Klemke-Jahn is a pioneering inventor whose work in macrolactone derivatives has the potential to impact the treatment of fungal disorders. Her contributions to the pharmaceutical industry highlight the importance of innovation in healthcare.